ArticleCommunications medicine2026

HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir.

Gilbert Mchantaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.